Kolexia
Fraboulet Gislaine Pneumologie
Fraboulet Gislaine
Pneumologie
Hôpital René Dubos
Pontoise, France
39 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du poumon Carcinome pulmonaire à petites cellules Carcinome pulmonaire non à petites cellules Carcinome épidermoïde Mésothéliome Folliculite Tumeurs de la plèvre Tumeurs du médiastin Carcinomes

Collaborateurs

Voir plus
Chouaid Christos
Chouaid Christos
Centre Hospitalier Intercommunal Créteil, Créteil, France
Monnet Isabelle
Monnet Isabelle
Centre Hospitalier Intercommunal Créteil, Créteil, France
Auliac Jean-Bernard
Auliac Jean-Bernard
Centre Hospitalier Intercommunal Créteil, Créteil, France
Oliviero Gérard
Oliviero Gérard
Direction De La Pmi Et Planification, Évry-Courcouronnes, France

Industries

Voir plus
Menarini
1 collaboration(s)
Dernière en 2021
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
BREC: Multicenter Phase III, Randomized Study to Evaluate Treatment Customized According to RAP80 and BRCA1 Assessment in Patients With Advanced Non-small-cell Lung Cancer
Essai Clinique (Spanish Lung Cancer Group)   29 janvier 2024
Potential Antiangiogenic Treatment Eligibility of Patients with Squamous Non-Small-Cell Lung Cancer: EPISQUAMAB Study (GFPC 2015-01).
Cancer management and research   27 décembre 2019
Tolérance et efficacité de l’osimertinib chez les patients (pts) octogénaires atteints de cancer du poumon non à petites cellules (CPNPC) porteurs d’une mutation T790M de l’Epidermal Growth Factor Receptor (EGFR) pré-traités par inhibiteurs de tyrosine-kinase (ITK) de l’EGFR. Étude Explore T790M, cohorte octogénaire
23e Congrès de Pneumologie de Langue Française   01 janvier 2019
Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study).
Oncotarget   02 janvier 2018
Impact of distance from surgery department on the outcome of patients followed for non-small-cell lung cancer in the respiratory department of nonacademic hospitals: Results of the KBP-2010-study.
Bulletin du cancer   29 septembre 2017
Octogenarians with EGFR-mutated non-small cell lung Cancer (NSCLC) treated by Tyrosine Kinase Inhibitor (TKI): A multicentric real world study assessing tolerance and efficacy. OCTOMUT study GFPC 07-15
Abstract Book of the 42nd ESMO Congress (ESMO 2017) 8-12 September 2017, Madrid, Spain   01 septembre 2017
P3.02b-127 NSCLC Patients Harboring HER2 Mutation: Clinical Characteristics and Management in Real World Setting. EXPLORE GFPC 02-14: Topic: EGFR RES
Abstracts from the IASLC 17th World Conference on Lung Cancer   01 janvier 2017
Circulating free tumour-derived DNA (ctDNA) to detect EGFR mutation in patients (pts) with advanced NSCLC (aNSCLC): French subset analysis of the ASSESS study
Abstract Book of the 41st ESMO Congress (ESMO 2016), 7-11 October 2016, Copenhagen, Denmark   01 octobre 2016
Non small cell lung cancer (NSCLC) patients harboring BRAF mutation: Clinical characteristics and management in real world setting. Cohort BRAF EXPLORE GFPC 02-14
Abstract Book of the 41st ESMO Congress (ESMO 2016), 7-11 October 2016, Copenhagen, Denmark   01 octobre 2016
Osimertinib in EGFR T790M positive advanced NSCLC (aNSCLC) – real–life data from the French temporary authorization for use (ATU) program
Abstract Book of the 41st ESMO Congress (ESMO 2016), 7-11 October 2016, Copenhagen, Denmark   01 octobre 2016